Sting Longevity: What He Has Said About Medication and Healthy Aging

What Sting Has Actually Said About His Health Practices

Sting has not publicly endorsed any specific prescription drug, hormone therapy, or peptide for longevity. His stated approach centers on physical discipline, not pharmacology.

In a 2023 interview with The Times, Sting described practicing Ashtanga yoga for roughly two hours every morning, a discipline he has maintained for more than three decades. He has credited this practice, alongside a largely plant-based diet and near-constant touring, for his stamina at an age when many peers have retired. He told Men's Health in a 2019 profile that he rarely drinks alcohol and treats food primarily as fuel.

What He Has Said About Avoiding Medication

Sting has not made sweeping anti-medication statements, but his public framing consistently positions lifestyle as primary. No published interview contains a specific claim that he uses testosterone replacement therapy, GLP-1 receptor agonists, metformin, rapamycin, or any other pharmacological longevity intervention.

That absence of disclosure is itself meaningful clinically. Men at 73 carrying his lean body composition and cardiovascular load from touring carry a different risk profile than the average man his age. Whether that profile warrants pharmacological support is a medical question, not a lifestyle one.

Where Inference Begins

Any statement connecting Sting to specific medications is inference, not documented fact. This article labels those moments clearly. The sections below examine the clinical science behind the practices he endorses, then outline what evidence-based medicine currently recommends for men in his age and health cohort.

The Clinical Evidence Behind Daily Yoga at His Age

Sting practices Ashtanga yoga daily for approximately two hours. That is a specific, high-volume commitment, and the clinical literature on yoga at that intensity offers measurable cardiovascular and metabolic outcomes.

Cardiovascular Effects

A 2015 systematic review and meta-analysis published in the European Journal of Preventive Cardiology (N=2,768 participants across 37 trials) found that yoga-based interventions reduced low-density lipoprotein cholesterol by a mean of 12.14 mg/dL and systolic blood pressure by approximately 5 mmHg compared with non-exercise controls. [1] For a man in his 70s with decades of that exposure, cumulative cardiovascular benefit may be substantial, though prospective trials in septuagenarians specifically are limited.

The American Heart Association's 2018 Scientific Statement on physical activity and cardiovascular health notes that moderate-to-vigorous physical activity for 150 minutes per week is associated with a 35% reduction in cardiovascular mortality. [2] Two hours of Ashtanga daily vastly exceeds that threshold.

Cortisol and Stress Hormones

Chronic psychological stress accelerates biological aging through telomere attrition and elevated cortisol. A 2013 randomized controlled trial in Psychoneuroendocrinology (N=72) found that an 8-week yoga intervention reduced morning salivary cortisol by 14% compared with a waitlist control group (P<0.05). [3] Sting has spoken in multiple interviews about yoga as a stress-management tool as much as a physical one.

Musculoskeletal Longevity

Sarcopenia, the age-related loss of muscle mass, begins accelerating after age 60 and is associated with increased all-cause mortality in older men. [4] Resistance-based yoga styles like Ashtanga load the musculoskeletal system through bodyweight movements. A 2019 review in Ageing Research Reviews concluded that yoga-based resistance loading produced statistically significant improvements in grip strength and lower-limb muscle mass in adults over 60 compared with sedentary controls. [4]

Diet: What a Plant-Forward Approach Does to Aging Biomarkers

Sting has described a largely plant-based diet with minimal processed food and alcohol. This maps closely to the Mediterranean dietary pattern, the most studied dietary intervention for longevity.

Mediterranean Diet and Mortality

The PREDIMED trial (Prevención con Dieta Mediterránea, N=7,447) demonstrated that a Mediterranean diet supplemented with extra-virgin olive oil or nuts reduced major cardiovascular events by approximately 30% compared with a low-fat control diet over a median follow-up of 4.8 years. [5] That trial enrolled adults aged 55 to 80, directly covering Sting's current age bracket.

Inflammation and Biological Age

Chronic low-grade inflammation, sometimes called inflammaging, is a primary driver of biological aging. A 2020 analysis in Gut (N=612 older adults across five European countries) found that adherence to a Mediterranean-style diet over 12 months reduced the inflammatory marker C-reactive protein and slowed gut microbiome aging markers compared with habitual Western-pattern diets. [6]

Alcohol Abstinence at 70-Plus

Sting's reported minimal alcohol use is clinically relevant. The Lancet Global Burden of Disease 2016 analysis (N=195 countries) concluded that the safest level of alcohol consumption is zero, with each additional drink per week incrementally increasing all-cause cancer risk. [7] In men over 70, hepatic alcohol metabolism slows, and even moderate intake raises fall risk, cognitive decline risk, and drug-interaction risk.

Testosterone and Hormonal Aging in Men at 73: The Clinical Picture

This section contains clinical inference. Sting has not disclosed testosterone therapy. The following describes what evidence-based medicine says about men his age and hormonal health.

How Testosterone Declines With Age

Men lose roughly 1 to 2% of total testosterone per year after age 30, according to the Massachusetts Male Aging Study, which followed 1,709 men over 9 years. [8] By age 70, a significant proportion of men have total testosterone below the 300 ng/dL threshold that the American Urological Association defines as hypogonadal. [9]

Symptoms of low testosterone in older men include fatigue, decreased muscle mass, reduced bone mineral density, mood changes, and sexual dysfunction. These are also symptoms frequently attributed to normal aging, which makes clinical diagnosis genuinely complex.

Does Testosterone Replacement Extend Life?

The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled trials in men 65 and older with confirmed low testosterone (N=788 in the sexual function trial alone), found that testosterone gel (50 mg/day titrated to physiologic levels) improved sexual function, mood, and bone mineral density at 12 months compared with placebo. [10] The trials did not demonstrate a survival benefit or a reduction in cardiovascular events. [10]

The Endocrine Society's 2018 Clinical Practice Guideline recommends testosterone therapy for men with confirmed symptomatic hypogonadism, specifically two morning testosterone readings below 300 ng/dL accompanied by clinical symptoms. [11] Prescribing testosterone to men with normal levels purely for anti-aging purposes is not currently supported by guideline-level evidence.

What a Highly Active 73-Year-Old Might Look Like Hormonally

High-volume endurance and resistance exercise maintains testosterone more effectively than sedentary aging. A 2016 study in the Journal of Clinical Endocrinology and Metabolism (N=195 older men) found that men who exercised vigorously for more than 3 hours per week had total testosterone levels approximately 15% higher than age-matched sedentary controls. [12] Sting's reported two-hour daily yoga practice would likely place him in the high-exercise category. This is inference, not confirmed data about him specifically.

GLP-1 Receptor Agonists and Longevity: Is There a Role for Healthy-Weight Men?

This section contains clinical inference. Sting appears lean based on public appearances and his reported activity level. GLP-1 receptor agonists like semaglutide are not indicated for men with normal BMI and no metabolic disease. This section explains why the conversation is happening in longevity medicine anyway.

The Weight-Loss Data

In STEP-1 (N=1,961), semaglutide 2.4 mg weekly produced a mean body-weight reduction of 14.9% at 68 weeks versus 2.4% in the placebo group (P<0.0001). [13] That trial enrolled adults with BMI of 30 or above, or BMI of 27 with at least one weight-related comorbidity.

Emerging Cardiovascular and Neuroprotective Signals

The SELECT trial (N=17,604 adults with cardiovascular disease and overweight or obesity, no diabetes) found that semaglutide 2.4 mg weekly reduced major adverse cardiovascular events by 20% versus placebo over a mean follow-up of 33.3 months. [14] Whether those benefits extend to metabolically healthy, normal-weight individuals is not yet established in controlled trials.

A 2024 review in Nature Aging noted that GLP-1 receptor agonism may reduce neuroinflammation through mechanisms independent of weight loss, citing preclinical data on microglial suppression. [15] Human longevity trials in healthy-weight adults are not yet complete, and off-label use in that population is not currently endorsed by the FDA or any major guideline body.

For a lean, active man his age, the risk-benefit calculation for semaglutide is genuinely unclear. The FDA approved semaglutide 2.4 mg (Wegovy) specifically for chronic weight management, not for general longevity. [16]

Metformin and Rapamycin: The Longevity Pharmacology Conversation

Two drugs generate the most discussion in the longevity medicine community outside of hormones: metformin and rapamycin. Neither has been publicly associated with Sting. Both have active clinical trials relevant to healthy aging.

Metformin

Metformin is a biguanide approved by the FDA for type 2 diabetes management since 1994. [17] Observational data, including a 2014 study in Diabetes Care (N=78,241 patients), suggested that diabetic patients on metformin lived longer than matched non-diabetic controls not taking the drug, raising the hypothesis that metformin has intrinsic longevity properties. [18]

The TAME trial (Targeting Aging with Metformin), a 6-year placebo-controlled trial of metformin 1,500 mg/day in adults aged 65 to 79 without diabetes (N=3,000 planned), is currently underway through Albert Einstein College of Medicine. Results are expected around 2026. [19] Metformin is not FDA-approved for longevity in non-diabetic individuals, and prescribing it off-label for that purpose remains speculative pending TAME results.

Rapamycin

Rapamycin (sirolimus) inhibits mTOR (mechanistic target of rapamycin), a pathway associated with cellular senescence and aging. In mouse models, rapamycin extended median lifespan by 9 to 14% even when initiated late in life, according to a landmark 2009 paper in Nature (Harrison et al.). [20] Human data on longevity are limited to observational series and small trials. The drug carries meaningful immunosuppressive risks and is FDA-approved only for organ transplant rejection and specific cancers. [21]

Off-label use of low-dose rapamycin in healthy adults is growing in direct-to-consumer longevity clinics, but no randomized controlled trial has yet demonstrated lifespan or healthspan benefits in humans. Clinicians considering rapamycin for longevity should counsel patients on the evidence gap explicitly.

What Evidence-Based Preventive Medicine Recommends for Men at 73

Regardless of any specific individual's choices, the following represents current guideline-level recommendations for men in Sting's age group.

Cardiovascular Risk Screening

The ACC/AHA Pooled Cohort Equation should be used to calculate 10-year atherosclerotic cardiovascular disease (ASCVD) risk in all adults aged 40 to 79. [22] Men over 70 with no prior cardiovascular events but traditional risk factors (hypertension, dyslipidemia, smoking history, diabetes) are often candidates for statin therapy and low-dose aspirin discussions, though aspirin guidance has shifted significantly since the 2022 USPSTF update, which no longer recommends initiating aspirin in adults over 60 for primary prevention due to bleeding risk outweighing benefit. [23]

Bone Density and Fracture Risk

Men over 70 should have dual-energy X-ray absorptiometry (DEXA) screening for osteoporosis, according to the National Osteoporosis Foundation guidelines. [24] Fracture risk rises sharply with age, and even physically active older men may have subclinical bone density loss.

Cognitive Health Monitoring

The FINGER trial (N=1,260 Finnish adults aged 60 to 77 at elevated dementia risk) demonstrated that a multimodal lifestyle intervention combining diet, exercise, cognitive training, and vascular risk monitoring reduced cognitive decline by 25% at 2 years compared with general health advice alone. [25] Sting's reported combination of vigorous physical activity and active professional engagement aligns with the intervention arms of FINGER.

Hormone Panel and Metabolic Screening

Annual fasting glucose, HbA1c, lipid panel, and a morning testosterone level (if symptoms are present) are appropriate for men over 65 per standard preventive care frameworks from the American College of Physicians. Thyroid-stimulating hormone testing is also indicated given the prevalence of subclinical hypothyroidism in this age group.

The Honest Gap: What We Do Not Know About Sting's Health

Sting is a private individual who has chosen to share his lifestyle practices but not his medical history. The following represents what remains genuinely unknown and should not be assumed.

He may take statins, antihypertensives, or other common medications that he has simply not discussed publicly. These are not longevity medications per se but are among the most common chronic-disease prescriptions for men in his age cohort. A 2022 CDC National Health Statistics Report found that 57% of U.S. Adults aged 65 and over take three or more prescription medications regularly. [26]

He may or may not have had standard age-appropriate cancer screenings (prostate-specific antigen testing, colonoscopy, low-dose CT lung cancer screening if he ever smoked). These are not medications but are clinically inseparable from any honest longevity discussion for men his age.

Attributing his apparent vitality entirely to yoga and diet, while potentially accurate, is also a form of survivorship bias. Men who live vigorously into their 70s doing two hours of yoga daily are already a self-selected population. The causal arrow between his practices and his health is not established by his example alone.